The state Supreme Court heard arguments Monday on whether Pfizer provided a former employee sufficient language in an emailed document to require that she resolve all company issues through arbitration as opposed to litigation.

In Skuse v. Pfizer, the justices are considering whether to uphold the Appellate Division’s ruling from January 2019 that plaintiff Amy Skuse didn’t assent to the arbitration agreement with Pfizer because the term “acknowledge” next to the click box did not rise to the level of “agree.” The appeals panel ruled it simply wasn’t enough.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]